BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11878574)

  • 1. Analysis of TP53 mutations in relapsed childhood acute lymphoblastic leukemia.
    Gump J; McGavran L; Wei Q; Hunger SP
    J Pediatr Hematol Oncol; 2001 Oct; 23(7):416-9. PubMed ID: 11878574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exon 5 mutations in the p53 gene in relapsed childhood acute lymphoblastic leukemia.
    Blau O; Avigad S; Stark B; Kodman Y; Luria D; Cohen IJ; Zaizov R
    Leuk Res; 1997 Aug; 21(8):721-9. PubMed ID: 9379679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
    Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
    Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.
    Hof J; Krentz S; van Schewick C; Körner G; Shalapour S; Rhein P; Karawajew L; Ludwig WD; Seeger K; Henze G; von Stackelberg A; Hagemeier C; Eckert C; Kirschner-Schwabe R
    J Clin Oncol; 2011 Aug; 29(23):3185-93. PubMed ID: 21747090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP53 alterations in relapsed childhood acute lymphoblastic leukemia.
    Yu CH; Chang WT; Jou ST; Lin TK; Chang YH; Lin CY; Lin KH; Lu MY; Chen SH; Wu KH; Wang SC; Chang HH; Su YN; Hung CC; Lin DT; Chen HY; Yang YL
    Cancer Sci; 2020 Jan; 111(1):229-238. PubMed ID: 31729120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.
    Krentz S; Hof J; Mendioroz A; Vaggopoulou R; Dörge P; Lottaz C; Engelmann JC; Groeneveld TW; Körner G; Seeger K; Hagemeier C; Henze G; Eckert C; von Stackelberg A; Kirschner-Schwabe R
    Leukemia; 2013 Feb; 27(2):295-304. PubMed ID: 22699455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alterations of the p53 gene and clinical features in childhood acute lymphoblastic leukemia].
    Kawamua M; Hayashi Y; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Horibe K; Hongo T; Ueda K
    Rinsho Ketsueki; 1997 Sep; 38(9):719-26. PubMed ID: 9364861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia.
    Agirre X; Novo FJ; Calasanz MJ; Larráyoz MJ; Lahortiga I; Valgañón M; García-Delgado M; Vizmanos JL
    Mol Carcinog; 2003 Dec; 38(4):201-8. PubMed ID: 14639659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation.
    Xiao H; Wang LM; Luo Y; Lai X; Li C; Shi J; Tan Y; Fu S; Wang Y; Zhu N; He J; Zheng W; Yu X; Cai Z; Huang H
    Oncotarget; 2016 Jan; 7(3):2696-708. PubMed ID: 26527318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infrequent mutations in the P53 gene in primary human T-cell acute lymphoblastic leukemia.
    Jonveaux P; Berger R
    Leukemia; 1991 Oct; 5(10):839-40. PubMed ID: 1961018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia.
    Diccianni MB; Yu J; Hsiao M; Mukherjee S; Shao LE; Yu AL
    Blood; 1994 Nov; 84(9):3105-12. PubMed ID: 7949183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic abnormalities and TP53 and RAS gene profiles of childhood acute lymphoblastic leukemia in Morocco.
    Skhoun H; El Fessikh M; El Alaoui Al Abdallaoui M; Khattab M; Belkhayat A; Chebihi ZT; Hassani A; Abilkassem R; Agadr A; Dakka N; El Baghdadi J
    Arch Pediatr; 2024 May; 31(4):238-244. PubMed ID: 38679547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panel-based next-generation sequencing identifies prognostic and actionable genes in childhood acute lymphoblastic leukemia and is suitable for clinical sequencing.
    Ishida H; Iguchi A; Aoe M; Takahashi T; Tamefusa K; Kanamitsu K; Fujiwara K; Washio K; Matsubara T; Tsukahara H; Sanada M; Shimada A
    Ann Hematol; 2019 Mar; 98(3):657-668. PubMed ID: 30446805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Ph1)-positive acute leukemia.
    Nakai H; Misawa S; Tanaka S; Nishigaki H; Taniwaki M; Yokota S; Horiike S; Takashima T; Seriu T; Nakagawa H
    Leukemia; 1993 Oct; 7(10):1547-51. PubMed ID: 8412316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia.
    Beltinger C; Kurz E; Böhler T; Schrappe M; Ludwig WD; Debatin KM
    Blood; 1998 May; 91(10):3943-51. PubMed ID: 9573033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA sequence profile of TP53 gene mutations in childhood B-cell non-Hodgkin's lymphomas: prognostic implications.
    Klumb CE; Furtado DR; de Resende LM; Carriço MK; Coelho AM; de Meis E; Maia RC; Rumjanek FD
    Eur J Haematol; 2003 Aug; 71(2):81-90. PubMed ID: 12890146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients.
    Chen C; Bartenhagen C; Gombert M; Okpanyi V; Binder V; Röttgers S; Bradtke J; Teigler-Schlegel A; Harbott J; Ginzel S; Thiele R; Husemann P; Krell PF; Borkhardt A; Dugas M; Hu J; Fischer U
    Leuk Res; 2015 Sep; 39(9):990-1001. PubMed ID: 26189108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia.
    Case M; Matheson E; Minto L; Hassan R; Harrison CJ; Bown N; Bailey S; Vormoor J; Hall AG; Irving JA
    Cancer Res; 2008 Aug; 68(16):6803-9. PubMed ID: 18701506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia.
    Felix CA; Nau MM; Takahashi T; Mitsudomi T; Chiba I; Poplack DG; Reaman GH; Cole DE; Letterio JJ; Whang-Peng J
    J Clin Invest; 1992 Feb; 89(2):640-7. PubMed ID: 1737852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.
    Kawamura M; Ohnishi H; Guo SX; Sheng XM; Minegishi M; Hanada R; Horibe K; Hongo T; Kaneko Y; Bessho F; Yanagisawa M; Sekiya T; Hayashi Y
    Leuk Res; 1999 Feb; 23(2):115-26. PubMed ID: 10071127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.